NEW YORK ( TheStreet) -- Shares of Strategic Diagnostics (Nasdaq: SDIX) have taken a tremendous swing upward. The stock is trading at $2.68 as of 12:22 p.m. ET, 20.7% above Thursday's closing price of $2.22. Volume is at 295,904, 8.7 times the daily average of 34,200.

Strategic has a market cap of $46.2 million and is part of the health care sector and health services industry. Shares are up 26.1% year to date as of the close of trading on Thursday.

Strategic Diagnostics Inc., a biotechnology company, together with its subsidiaries, develops, manufactures, and markets proprietary products, services, and solutions in the pharmaceutical, biotechnology, diagnostics, food safety, and environmental markets.

TheStreet Ratings rates Strategic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. You can view the full Strategic Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
null